Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFBZ7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,987
Award facts
- Contract value 100% obligated
- $47,987.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,987 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 23, 2026, and carries no set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group is the sole contractor on this award with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to streamline pharmaceutical supply across the Department of Defense. The PPV-G GEN V program establishes multiple regional prime vendor contractors to deliver a comprehensive range of pharmaceuticals, biologics, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous prior delivery orders and its classification as a critical pharmaceutical supplier for federal military medical operations demonstrate the company's capability to meet the specialized pharmaceutical requirements of the Defense Logistics Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FFBZ7?
SPE2DR26FFBZ7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FFBZ7 worth?
The government has obligated $47,987 on SPE2DR26FFBZ7.
Is contract SPE2DR26FFBZ7 an order under another contract?
Yes. SPE2DR26FFBZ7 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBZ7 competed?
The extent of competition for SPE2DR26FFBZ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award